Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream is a semisolid preparation dispensed in a pump mechanism. This formulation is designed for convenient and controlled application on the skin. It is used for localized treatment of Allergic Conjunctivitis, Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, Giant Papillary Conjunctivitis, and Blepharitis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specially compounded topical cream that contains Azelastine Hydrochloride 0.15% and Brimonidine Tartrate 0.5%. This unique formulation is designed to address a range of conditions, including allergic conjunctivitis, vernal keratoconjunctivitis, and ocular itching associated with allergic conjunctivitis.
Azelastine Hydrochloride is an antihistamine that functions by inhibiting the action of histamine, a substance in the body that triggers allergic symptoms. On the other hand, Brimonidine Tartrate is an alpha-2 agonist that operates by reducing the amount of fluid in the eye, thereby minimizing redness and swelling.
This compounded formulation is a semisolid preparation dispensed in a pump mechanism, designed for convenient and controlled application on the skin for localized treatment or absorption of active ingredients. It is intended to be applied to the affected area twice daily, or as directed by a healthcare provider. It is crucial to adhere to the instructions provided by the healthcare provider and to avoid contact with the eyes.
If you have any questions about this formulation or how it can assist in treating your condition, please do not hesitate to contact us at Bayview Pharmacy. We are here to help you identify the most suitable treatment option for your specific needs.
Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream is a compounded formulation designed for the treatment of allergic conjunctivitis, vernal keratoconjunctivitis, and blepharitis. This unique combination of active ingredients works synergistically to block the release of histamine, a chemical that triggers inflammation and itching, and to decrease the production of tears, providing relief from these conditions.
The cream is dispensed in a pump mechanism, which allows for convenient and controlled application on the skin. It is intended for localized treatment, meaning it should be applied directly to the affected area. The recommended dosage is twice daily, or as directed by your healthcare provider. It is crucial to avoid contact with the eyes, nose, and mouth. In case of accidental contact, rinse the area thoroughly with water.
Patients should be aware of potential side effects, which may include temporary blurred vision, stinging, burning, or redness at the application site. If these side effects persist or worsen, it is recommended to contact your healthcare provider immediately.
It is also important to note that this medication should not be used in patients with a known hypersensitivity to either Azelastine HCl or Brimonidine Tartrate. Furthermore, it should not be used in combination with other topical medications or with contact lenses, as this may increase the risk of side effects or cause irritation.
If you have any questions or concerns about the use of Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream, please do not hesitate to reach out to your healthcare provider for further guidance.
Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream is a compounded medication designed to treat conditions such as allergic conjunctivitis, vernal keratoconjunctivitis, and seasonal allergic rhinitis. This combination medication works by inhibiting the action of certain natural substances that trigger inflammation and redness in the eyes and nose. The azelastine hydrochloride component of the cream helps to alleviate itching, redness, and tearing of the eyes, while the brimonidine tartrate component aids in reducing redness and swelling of the eyes.
To use this medication, apply a thin layer of the cream to the affected area of the eye or nose, typically twice daily or as directed by your healthcare provider. The cream should be gently rubbed into the skin until it is fully absorbed. It is crucial to adhere to the recommended dose and not to use it more frequently than prescribed by your doctor.
Before using Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream, it is essential to inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. It is equally important to disclose any other medications you are currently taking, including vitamins and supplements, to your doctor.
If you have any queries about using Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream, do not hesitate to reach out for further information and guidance.
This Azelastine HCl 0.15%/Brimonidine Tartrate 0.5% Topical Cream is a compounded formulation designed for localized treatment or absorption of active ingredients through the skin. It is dispensed in a pump mechanism for convenient and controlled application. This formulation may be used to treat a variety of ocular conditions including dry eye syndrome, corneal ulcers, and blepharospasm. It may also be beneficial in reducing the risk of corneal neovascularization, corneal scarring, infection in patients with ocular trauma, inflammation, corneal edema, corneal thinning, and corneal opacity.
Patients should be aware that this formulation may cause side effects such as burning, stinging, and redness of the eyes. If any of these side effects occur, it is recommended to contact a healthcare provider. Furthermore, prescribers should note that this formulation may interact with other medications and should be used with caution in patients with a history of glaucoma or other ocular conditions. For any questions or concerns regarding the use of this formulation, please consult with a healthcare professional.
This is a compounded formulation of two active ingredients, Azelastine HCl and Brimonidine Tartrate, in a semisolid preparation. It is designed for topical application on the skin for localized treatment.
The cream is dispensed in a pump mechanism, which allows for convenient and controlled application on the skin.
The active ingredients in this cream are Azelastine HCl at a concentration of 0.15% and Brimonidine Tartrate at a concentration of 0.5%.
The pump mechanism is designed to provide a convenient and controlled way to apply the cream on the skin. It ensures that the right amount of cream is dispensed each time.
You should apply this cream to the affected area as directed by your healthcare provider. The pump mechanism will dispense the right amount of cream for application.
Generally, this cream can be used on all skin types. However, if you have sensitive skin or any specific skin conditions, you should consult with your healthcare provider before using this cream.
If you experience any side effects after using this cream, you should immediately stop using it and consult with your healthcare provider.
Before using this cream with other skincare products, it is recommended to consult with your healthcare provider to avoid any potential interactions.
This cream should be stored at room temperature, away from heat and direct sunlight. Make sure the cap is tightly closed when not in use.
If you miss a dose, apply it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose to catch up.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
